Skip to content

Drug interactions

Argatroban + Nintedanib

Severity: Moderate

Argatroban and Nintedanib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nintedanib inhibits VEGF receptor signaling and has been associated with an increased risk of bleeding. In patients on full-dose anticoagulation such as argatroban, bleeding risk may be further increased.

What this interaction means in plain words

Argatroban and Nintedanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Argatroban belongs to Cardiovascular; Nintedanib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive pharmacodynamic effect: VEGFR inhibition by nintedanib affects vascular integrity and hemostasis while argatroban inhibits thrombin.

What to do

Monitor patients closely for bleeding and check aPTT and hemoglobin; use nintedanib only if the anticipated benefit outweighs the bleeding risk.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Argatroban and Nintedanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Argatroban with Nintedanib?

MediHelp rates the interaction as moderate. Argatroban and Nintedanib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Nintedanib inhibits VEGF receptor signaling and has been associated with an increased risk of bleeding. In patients on full-dose anticoagulation such as argatroban, bleeding risk may be further increased.

How serious is the interaction between Argatroban and Nintedanib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor patients closely for bleeding and check aPTT and hemoglobin; use nintedanib only if the anticipated benefit outweighs the bleeding risk.

What other medicines interact with Argatroban?

MediHelp also lists interactions of Argatroban with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Argatroban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in